Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Amvis Holdings Inc. (7071:JPX), powered by AI.
Amvis Holdings Inc. is currently trading at ¥333. View real-time AI analysis on Alpha Lenz.
View the latest insider trading data for Amvis Holdings Inc. on Alpha Lenz.
Amvis Holdings Inc.'s P/E ratio is 8.9.
“Amvis Holdings Inc. trades at a P/E of 8.9 (undervalued) with solid ROE of 10.6%. 3Y revenue CAGR of 28.7% highlights clear growth momentum.”
Ask for details →Amvis Holdings Inc. is a renowned entity in the healthcare services industry, primarily focused on providing comprehensive medical support and home-visit care services in Japan. The company plays a crucial role by offering high-quality at-home medical and palliative care to patients with chronic illnesses and terminal conditions. It operates a network of strategically located centers to efficiently serve a diverse clientele, including elderly patients needing specialized care. Amvis Holdings Inc. emphasizes a patient-centered approach, ensuring personalized care plans tailored to individual needs, which underscores its commitment to improving quality of life and delivering compassionate support. Its services are pivotal in addressing the growing demand for healthcare solutions amidst Japan's aging population. By integrating advanced medical technologies and robust operational systems, Amvis Holdings enhances service delivery efficiency and reliability, making significant contributions to the healthcare sector in Japan. As a key player in the market, Amvis Holdings Inc. is integral in supporting both private and public healthcare initiatives, helping bridge the gap in home medical services and community health resources.
“Amvis Holdings Inc. trades at a P/E of 8.9 (undervalued) with solid ROE of 10.6%. 3Y revenue CAGR of 28.7% highlights clear growth momentum.”
Ask for details →Amvis Holdings Inc. (ticker: 7071) is a company listed on JPX in the Healthcare sector (Medical Care Facilities). It has approximately 4,046 employees. Market cap is $32.5B.
The current price is 333 with a P/E ratio of 8.88x and P/B of 0.9x.
ROE is 10.56% and operating margin is 12.53%. Annual revenue is $49.2B.